Correlation Between Launch One and Lipocine

Can any of the company-specific risk be diversified away by investing in both Launch One and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Launch One and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Launch One Acquisition and Lipocine, you can compare the effects of market volatilities on Launch One and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Launch One with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of Launch One and Lipocine.

Diversification Opportunities for Launch One and Lipocine

-0.5

Correlation Coefficient

Launch One  Lipocine

Very good diversification

The 3 months correlation between Launch and Lipocine is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Launch One Acquisition and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and Launch One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Launch One Acquisition are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of Launch One i.e., Launch One and Lipocine go up and down completely randomly.

Pair Corralation between Launch One and Lipocine

Given the investment horizon of 90 days Launch One is expected to generate 6.56 times less return on investment than Lipocine. But when comparing it to its historical volatility, Launch One Acquisition is 47.07 times less risky than Lipocine. It trades about 0.18 of its potential returns per unit of risk. Lipocine is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  520.00  in Lipocine on October 11, 2024 and sell it today you would earn a total of  3.00  from holding Lipocine or generate 0.58% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Launch One Acquisition  vs.  Lipocine

Launch One Acquisition

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Launch One Acquisition are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Launch One is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Lipocine

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Lipocine are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain fundamental indicators, Lipocine may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Launch One and Lipocine

The main advantage of trading using opposite Launch One and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Launch One position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.

The idea behind Launch One Acquisition and Lipocine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.